Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485754 ((R)-3-(5-fluorothiophen-2- yl)-3-(isoquinolin-5-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485784 ((S)-3-(3-Fluorothiophen-2-yl)-3-(isoquinolin-5-ylo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485761 ((R)-N-methyl-3-((1- methylisoquinolin-5- yl)oxy)-3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485780 ((S)-3-(5-Chlorothiophen-2-yl)-N-methyl-3-(quinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485764 ((R)-N-methyl-3-((1- methylisoquinolin-8- yl)oxy)-3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485768 ((R)-3-((2,4- dimethylquinolin-5- yl)oxy)-N-methyl-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485744 (3-(5-fluorothiophen-2-yl)- N-methyl-3-(quinolin-5-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485747 (3-(5-fluorothiophen-2-yl)- 3-(isoquinolin-5-yloxy)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485707 (N-ethyl-3-(isoquinolin-5- yloxy)-3-(thiophen-2- yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485711 ((S)-N-methyl-3-(quinolin- 5-yloxy)-3-(thiophen-2- ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485718 (5-(3-(methylamino)-1- (thiophen-2- yl)propoxy)isoq...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485791 ((R)-5-(3-(ethylamino)-1- (thiophen-2- yl)propoxy)i...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485692 (US10941138, Example 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485705 (3-(isoquinolin-5-yloxy)- N-methyl-3-(thiophen-2- y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485711 ((S)-N-methyl-3-(quinolin- 5-yloxy)-3-(thiophen-2- ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485713 ((S)-3-(isoquinolin-5- yloxy)-N-methyl-3- (thiophen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485744 (3-(5-fluorothiophen-2-yl)- N-methyl-3-(quinolin-5-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485747 (3-(5-fluorothiophen-2-yl)- 3-(isoquinolin-5-yloxy)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485748 (3-(3-fluorothiophen-2-yl)- 3-(isoquinolin-5-yloxy)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485752 ((S)-3-(5-fluorothiophen-2- yl)-3-(isoquinolin-5-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485754 ((R)-3-(5-fluorothiophen-2- yl)-3-(isoquinolin-5-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485755 ((R)-3-(5-fluorothiophen-2- yl)-N-methyl-3-(quinoli...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485758 (3-(isoquinolin-5-yloxy)-N- methyl-3-(thiophen-3- y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485764 ((R)-N-methyl-3-((1- methylisoquinolin-8- yl)oxy)-3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuroepithelial cell-transforming gene 1 protein (Homo sapiens) | BDBM485770 ((S)-3-(isoquinolin-5- yloxy)-N-methyl-3- (thiophen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer contain... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485780 ((S)-3-(5-Chlorothiophen-2-yl)-N-methyl-3-(quinolin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485755 ((R)-3-(5-fluorothiophen-2- yl)-N-methyl-3-(quinoli...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485753 ((S)-3-(5-fluorothiophen-2- yl)-N-methyl-3-(quinoli...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485758 (3-(isoquinolin-5-yloxy)-N- methyl-3-(thiophen-3- y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485759 (N-methyl-3-(quinolin-5- yloxy)-3-(thiophen-3- yl)p...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485760 (3-(isoquinolin-8-yloxy)-N- methyl-3-(thiophen-3- y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485762 ((R)-3-(isoquinolin-5- yloxy)-N-methyl-3- (thiophen...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485763 ((R)-3-(isoquinolin-8- yloxy)-N-methyl-3- (thiophen...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485774 (N-methyl-3-(quinolin-5- yloxy)-3-(thiazol-2- yl)pr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485777 (US10941138, Example 75) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485778 ((S)—N-Methyl-3-(quinolin-5-yloxy)-3-(thiazol-2-yl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485782 ((S)-3-(5-Fluorothiophen-2-yl)-3-(isoquinolin-8-ylo...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485784 ((S)-3-(3-Fluorothiophen-2-yl)-3-(isoquinolin-5-ylo...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485788 ((S)-3-(3-Fluorothiophen-2-yl)-3-(isoquinolin-8-ylo...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485790 ((R)-N-ethyl-3-(isoquinolin- 5-yloxy)-3-(thiophen-2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485765 ((R)-N-methyl-3-(quinolin- 5-yloxy)-3-(thiophen-3- ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485769 ((S)-N-methyl-3-(quinolin- 5-yloxy)-3-(thiophen-3- ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485743 (3-(5-chlorothiophen-2-yl)- N-methyl-3-(quinolin-5-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485748 (3-(3-fluorothiophen-2-yl)- 3-(isoquinolin-5-yloxy)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485749 (3-(3-fluorothiophen-2-yl)- 3-(isoquinolin-8-yloxy)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485750 (3-(3-fluorothiophen-2-yl)- N-methyl-3-(quinolin-5-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485751 (3-(5-fluorothiophen-2-yl)- 3-(isoquinolin-8-yloxy)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485705 (3-(isoquinolin-5-yloxy)- N-methyl-3-(thiophen-2- y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485712 ((S)-3-(isoquinolin-8- yloxy)-N-methyl-3- (thiophen...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 (Homo sapiens (Human)) | BDBM485715 ((R)-3-(isoquinolin-8- yloxy)-N-methyl-3- (thiophen...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH... | US Patent US10941138 (2021) BindingDB Entry DOI: 10.7270/Q2XW4NXF | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 193 total ) | Next | Last >> |